DOPHEXINE 20 mg/g прах за прилагане във вода за пиене/мляко 20 mg/g Bulgārija - bulgāru - БАБХ (Българска агенция по безопасност на храните)

dophexine 20 mg/g прах за прилагане във вода за пиене/мляко 20 mg/g

dopharma research b.v. - Бромгексин - прах за прилагане във вода за пиене/мляко - 20 mg/g - говеда, патици, пилета, прасета, пуйки

Pexion Eiropas Savienība - bulgāru - EMA (European Medicines Agency)

pexion

boehringer ingelheim vetmedica gmbh - imepitoin - Други противоэпилептические средства, противоэпилептические средства - Кучета - За намаляване на честотата на генерализирани припадъци, дължащи се на идиопатична епилепсия при кучета за употреба след внимателна оценка на алтернативните възможности за лечение.

Vaxxitek HVT+IBD Eiropas Savienība - bulgāru - EMA (European Medicines Agency)

vaxxitek hvt+ibd

boehringer ingelheim vetmedica gmbh - Рекомбинантный герпесвирус Турция, прецедете vhvt013-69, на живо - Имуномодулатори за птици, домашни животни, имуномодулатори - embryonated eggs; chicken - За активна имунизация на пилета:за предотвратяване на смъртността и намаляване на клинични признаци и лезии на инфекциозна болест Бурсальной . За да се намали смъртността, клинични признаци и лезии на болестта на Марек .

BUTAGRAN EQUI, 200 mg/g, перорален прах за коне 200 mg/g Bulgārija - bulgāru - БАБХ (Българска агенция по безопасност на храните)

butagran equi, 200 mg/g, перорален прах за коне 200 mg/g

dopharma research b.v - Бутадион - перорален прах - 200 mg/g - коне

DETOGESIC 10 mg/ml solution for injection for horses 1 mg/ml Bulgārija - bulgāru - БАБХ (Българска агенция по безопасност на храните)

detogesic 10 mg/ml solution for injection for horses 1 mg/ml

vetcare limited - detomidine хидрохлорид - инжекционен разтвор - 1 mg/ml - коне

INGELVAC MycoFLEX инжекционна суспензия за прасета/ injectable suspension for pigs ≥ 1 OA Bulgārija - bulgāru - БАБХ (Българска агенция по безопасност на храните)

ingelvac mycoflex инжекционна суспензия за прасета/ injectable suspension for pigs ≥ 1 oa

boehringer ingelheim vetmedica gmbh - hyopneumoniae микоплазма - инжекционна суспензия - ≥ 1 oa - прасета

PHENOXYPEN WSP 325 mg/g powder for oral solution for chickens 293 mg/g Bulgārija - bulgāru - БАБХ (Българска агенция по безопасност на храните)

phenoxypen wsp 325 mg/g powder for oral solution for chickens 293 mg/g

dopharma research b.v. - Феноксиметилпенициллин - перорален прах - 293 mg/g - пилета

REPROCYC PRRS EU lyophilisate and solvent for suspension for injection for pigs Bulgārija - bulgāru - БАБХ (Българска агенция по безопасност на храните)

reprocyc prrs eu lyophilisate and solvent for suspension for injection for pigs

boehringer ingelheim vetmedica gmbh - porcine reproductive & respiratory syndrome (prrs) virus, strain 94881, live attenuated - лиофилизат и разтворител за инжекционна суспензия - 10 на 3, 9 степен - 10 на 7 степен tcid50 - прасета

T.S. SOL Bulgārija - bulgāru - БАБХ (Българска агенция по безопасност на храните)

t.s. sol

dopharma research b.v. - sulfamethoxazone; Триметоприм - перорален разтвор - 20 mg/ml; 80 mg/ml - прасета, птици

Alymsys Eiropas Savienība - bulgāru - EMA (European Medicines Agency)

alymsys

mabxience research sl - бевацизумаб - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - Антинеопластични средства - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.